The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure. - Wikidata - wikimedia - TriplyDB

The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure.

The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure.

http://www.wikidata.org/entity/Q37301554

about

Randomized comparison of sevoflurane versus propofol-remifentanil on the cardioprotective effects in elderly patients with coronary heart disease.

P2860

Q41364606-A60E2211-3182-43E8-95F9-9AEDA8EA1BDC

P2860

The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure.

http://www.wikidata.org/entity/Q37301554

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Relationship between Serum ...... s with Systolic Heart Failure.

@en

The Relationship between Serum ...... s with Systolic Heart Failure.

@nl

type

label

The Relationship between Serum ...... s with Systolic Heart Failure.

@en

The Relationship between Serum ...... s with Systolic Heart Failure.

@nl

prefLabel

The Relationship between Serum ...... s with Systolic Heart Failure.

@en

The Relationship between Serum ...... s with Systolic Heart Failure.

@nl

P1433

Q37301554-9D780732-4FF8-473D-8D6E-A884A4F9ABB5

P1476

Q37301554-098CB0AF-5C1D-4784-9F09-1C7F2A3E618B

P2093

Q37301554-21B0E1B6-B9B8-49FE-81F1-49504E866CC6

Q37301554-3ABE44B2-D9CD-4A6C-8BEE-B8F4C45DD048

Q37301554-B3C570FA-B6F2-4386-A9E1-8D2013902EBE

Q37301554-D76AE4E6-5FCC-4D6E-99D9-923BCAF969AB

P2860

Q37301554-01627EF5-9BB1-4251-872D-207747923289

Q37301554-01B1560C-C4DF-4401-A944-1CA35E2884A6

Q37301554-1359B851-B94A-416E-9F07-9EE1C90B14CE

Q37301554-174FD923-24DF-4672-B236-7064A3B557CE

Q37301554-29EA786B-6134-46BD-93F1-3D2CA286AF90

Q37301554-7AA80D68-3D63-49FB-9613-79DFF1EDBB41

Q37301554-84D455AB-B232-4227-A383-7933ECF5D022

Q37301554-BAE5F82B-87CC-4A49-8475-62F5A3D198FD

Q37301554-BC284F66-7C01-4C4D-B4A1-9A009505C172

Q37301554-D98A838A-776F-42C7-A0E1-C431F4929FE8

P304

Q37301554-DFAC5680-4FC9-4475-AA19-6F79FCBF55F3

P31

Q37301554-7C12A755-23E8-44A5-B5A3-F7970DEE2461

P356

Q37301554-F9A0345A-30C6-44C5-87B2-50560D2C8BD0

P433

Q37301554-77C55906-81B6-49F6-97C4-3E1A3CA29FB5

P478

Q37301554-8BBCFB62-71BF-4C9A-AA72-2CF759AF090D

P577

Q37301554-945AA408-72AC-4CFC-8351-1BD3AB40237B

P5875

Q37301554-0F87855A-B4AF-4632-AF8E-93644A5A73F1

P698

Q37301554-F134062C-FA34-45AF-A993-1DBEC566BAD0

P921

Q37301554-53137674-8F53-4E23-B0BD-35C7CF554365

Q37301554-92B4244F-AC52-4400-AA5F-37254FD54EBE

P932

Q37301554-74FFF4F5-3208-47FD-AE48-4BDEDCB189A7

P356

P1433

Journal of cardiovascular and thoracic research

P1476

The Relationship between Serum ...... s with Systolic Heart Failure.

@en

P2093

Mahdiye Shekhi

http://www.w3.org/2001/XMLSchema#string

Saeedeh Mazlomzadeh

http://www.w3.org/2001/XMLSchema#string

Sepideh Sokhanvar

http://www.w3.org/2001/XMLSchema#string

Zahra Golmohammadi

http://www.w3.org/2001/XMLSchema#string

P2860

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Natriuretic peptides in the diagnosis and management of heart failure

Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides.

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.

P304

57-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5681/JCVTR.2011.012

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258704267

http://www.w3.org/2001/XMLSchema#string

P698

24250954

http://www.w3.org/2001/XMLSchema#string

P921

P932

3825328

http://www.w3.org/2001/XMLSchema#string